Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines
Open Access
- 27 December 2017
- journal article
- research article
- Published by American Society for Microbiology in mSphere
- Vol. 2 (6) , e00305-17
Abstract
Epstein-Barr virus (EBV) is a common human herpesvirus that establishes latency in B cells. While EBV infection is asymptomatic for most individuals, immune-suppressed individuals are at significantly higher risk of a form of EBV latent infection in which infected B cells are reactivated, grow unchecked, and generate lymphomas. This form of latency is modeled in the laboratory by infecting B cells from the blood of normal human donorsin vitro. In this model, we identified a protein called CD226 that is induced by EBV but is not normally expressed on B cells. Rather, it is known to play a role in aggregation and survival signaling of non-B cells in the immune system. Cultures of EBV-infected cells adhere to one another in “clumps,” and while the proteins that are responsible for this cellular aggregation are not fully understood, we hypothesized that this form of cellular aggregation may provide a survival advantage. In this article, we characterize the mechanism by which EBV induces this protein and its expression on lymphoma tissue and cell lines and characterize EBV-infected cell lines in which CD226 has been knocked out.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (R01-CA140337)
- HHS | NIH | National Cancer Institute (T32-CA009111)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (5P30-AI064518)
- HHS | NIH | National Institute of Dental and Craniofacial Research (R01-DE025994)
This publication has 40 references indexed in Scilit:
- Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF-κB ActivationJournal of Virology, 2012
- Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growthProceedings of the National Academy of Sciences, 2011
- Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer InfectionPLOS Pathogens, 2011
- An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B CellsCell Host & Microbe, 2010
- c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B CellsJournal of Virology, 2009
- MDM2-Dependent Inhibition of p53 Is Required for Epstein-Barr Virus B-Cell Growth Transformation and Infected-Cell SurvivalJournal of Virology, 2009
- Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answersInternational Journal of Cancer, 2009
- Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cellsProceedings of the National Academy of Sciences, 2006
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989